Showing results (11-20 of 277) with videos related to
Sort By:
Pageof 28
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 2, 2008
The insulin-like growth factor pathway in lung cancerRafal Dziadziuszko, D Ross Camidge, Fred R HirschJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2009
ALK gene rearrangements: a new therapeutic target in a molecularly defined subset of non-small cell lung cancerBenjamin Solomon, Marileila Varella-Garcia, D Ross CamidgeClinical Lung Cancer|July 28, 2009
The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancersD Ross Camidge, Rafal Dziadziuszko, Fred R HirschJTO Clinical and Research Reports|August 2, 2024
L2086F Mutant ROS1-Rearranged NSCLC Resistant to Repotrectinib Responds to Cabozantinib: A Case ReportUrs Weber, Kurtis D Davies, D Ross CamidgeAmerican Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|April 15, 2022
Extending Our Reach: Expanding Enrollment in Brain Metastases and Primary Brain Tumor Clinical TrialsEudocia Q Lee, D Ross Camidge, Gautam MehtaNature Reviews. Clinical Oncology|July 2, 2014
Acquired resistance to TKIs in solid tumours: learning from lung cancerD Ross Camidge, William Pao, Lecia V SequistThe Lancet. Oncology|September 2, 2008
Targeted manipulation of apoptosis in cancer treatmentJustin A Call, S Gail Eckhardt, D Ross CamidgeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 14, 2016
Transient Asymptomatic Pulmonary Opacities Occurring during Osimertinib TreatmentSinead A Noonan, Peter B Sachs, D Ross CamidgeJournal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 6, 2024
The Use of Investigator-Assigned Subjective or Judgmental Efficacy and Toxicity Reporting in Early Phase Clinical Trials of Lung Cancer TreatmentsWilliam J Phillips, Alexander S Watson, D Ross CamidgeNature Reviews. Clinical Oncology|February 6, 2019
Comparing and contrasting predictive biomarkers for immunotherapy and targeted therapy of NSCLCD Ross Camidge, Robert C Doebele, Keith M KerrPageof 28